Change of receipt date and clarifications to requirements for PAR 09-066, “Partnerships for CAM Clinical Translational Research (PCCTR) (U19)”
Notice Number: NOT-AT-10-002
Update: The following update relating to this announcement has been issued:
Release Date: February 3, 2010
Letters of Intent Receipt Date(s): April 28, 2010; April 27, 2011
Application Receipt Date(s): May 28, 2010; May 27, 2011
Peer Review Date(s): July 2010, July 2011
Council Review Date(s): August 2010, August 2011
Earliest Anticipated Start Date: October 2010, October 2011
Expiration Date: May 28, 2011
National Center for Complementary and Alternative Medicine (NCCAM), (http://www.nccam.nih.gov/)
The purpose of this notice is to change the receipt dates in 2010 and 2011 as well as to clarify certain aspects of the partnership between CAM and research intensive institutions. See “Partnerships for CAM Clinical Translational Research (PCCTR) (U19)”, PAR-09-066.
- The 2010 receipt date has been moved up one month to allow for a possible award in FY2010. In addition, the 2011 receipt date has been moved up one month to allow for a possible award in FY2011.
- The goal of the Partnerships in CAM Clinical Translational Research (PCCTR) initiative is to further rigorous clinical CAM research by fostering multi-disciplinary collaborations between clinical experts at CAM institutions and clinical and translational research experts at research-intensive partner institutions.
- The distribution of resources to specific components of the program should be explained in the budget justification, and in the leadership plan or overview as appropriate. The distribution should reflect scientific needs. There is no requirement that a certain percentage of funds be distributed to the CAM institution; however, salary support should be commensurate with percent effort.
- The overview section must address the overall objectives of this multi-component Center, the relationships among the participating institutions, and between the research projects and the administrative structure, and how they will each contribute to the overall objectives and the overall budget. The contributions of the various institutions do not need to be equal, but should be based on each component’s specific skills, resources and expertise relative to the research proposed. The Overview section should describe how the PCCTR components would integrate with each other to support development of translational or clinical research expertise at the participating CAM institution(s), and to support development of CAM research at the participating research-intensive institutions.
- A Personal Statement must be incorporated as Part A of each biographical sketch. This statement should explain the qualifications of the person relevant to their role in the project, including CAM expertise and experience with specific methodology. The section may also include information about how the individual’s participation will contribute to the goal of developing translational or clinical research expertise at the participating CAM institution(s) or the goal of development of CAM research at the participating research-intensive institution(s). .
- No cores are allowed. Administration of the Center should be described in the Overview section of the application. No scientific cores are allowed.
A single, numerical overall impact/priority score (10 to 90) will be assigned to each PCCTR application as a whole, based on the scientific merit of the research projects and the evaluation of the PD/PI (s), institutional commitment, resources and the impact of the partnership on developing CAM research at all participating institutions.
Peer Review contact:
Dale Birkle Dreer, Ph.D.
Chief, Office of Scientific Review
National Center for Complementary and Alternative Medicine (NCCAM)
6707 Democracy Blvd. Suite 401
Bethesda, MD 20892-5475 (use 20817 for private courier services)
Telephone: (301) 451-6570
FAX: (301) 480-2419
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices